Back to Global NewsPublished: 28 Feb 2026Download AppJoin TelegramWhy Ascendis' Weekly Growth Drug Could Spark a Rare‑Disease Investing Boom#Ascendis Pharma#YUVIWEL#FDA Approval#Biotech#Rare Diseases#InvestingDownload AppJoin CommunityShare Article